The Expanding Peptide Conjugate Landscape: Strategies for Complex Peptide Synthesis, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how synthesis strategies can support the development of increasingly complex peptide conjugates. The featured speaker will discuss route selection, conjugation, purification and analytical methods across peptide-drug, radionuclide, oligonucleotide and antibody-peptide conjugates. Attendees will also explore case studies showing how these choices can affect purity, scale, timelines and overall project execution.

TORONTO, Oct. 14, 2026 /PRNewswire/ -- With peptide conjugate therapies achieving blockbuster sales and around 300 peptide-drug conjugates having entered clinical development, interest is expanding across new conjugate types and therapeutic applications. This webinar examines practical approaches to navigating the synthesis and development challenges associated with increasingly complex peptide conjugates.

Radionuclide-drug conjugates (RDCs), peptide-drug conjugates (PDCs), peptide-oligonucleotide conjugates (POCs)/peptide phosphorodiamidate morpholino oligomers (PPMOs) and antibody-peptide conjugates (APCs) pose distinct synthesis challenges shaped by peptide structure, linker and payload properties and conjugation chemistry. Following a brief overview of these conjugate types, the featured speaker will discuss how synthesis strategy, route selection and downstream processing work together to meet purity, scale and timeline requirements. Case studies will demonstrate how these approaches are applied in practice, including the influence of conjugation, purification and analytical methods on project execution.

The session will also examine how peptide synthesis connects with peptide DNA-encoded library (DEL), biology, chemistry and early-stage CMC capabilities, providing additional context for the development of complex peptide conjugates.

Register for this webinar to learn how peptide synthesis strategies can support the purity, scale and execution of complex peptide conjugate programs.

Join Yuyan Chen, PhD, Senior Director of Chemistry, BioDuro, for the live webinar on Friday, October 30, 2026, at 11am EDT (4pm CET / EU-Central).

For more information, or to register for this event, visit The Expanding Peptide Conjugate Landscape: Strategies for Complex Peptide Synthesis.

ABOUT XTALKS

Xtalks – The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.

Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.

To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/

Contact:
Soumya Shashikumar
Tel: +1 (416) 977-6555 x371
Email: [email protected]

SOURCE Xtalks